rs1051336
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_019111.5(HLA-DRA):c.*175G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.151 in 153,648 control chromosomes in the GnomAD database, including 1,899 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.15 ( 1894 hom., cov: 31)
Exomes 𝑓: 0.083 ( 5 hom. )
Consequence
HLA-DRA
NM_019111.5 3_prime_UTR
NM_019111.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.338
Publications
40 publications found
Genes affected
HLA-DRA (HGNC:4947): (major histocompatibility complex, class II, DR alpha) HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. This molecule is expressed on the surface of various antigen presenting cells such as B lymphocytes, dendritic cells, and monocytes/macrophages, and plays a central role in the immune system and response by presenting peptides derived from extracellular proteins, in particular, pathogen-derived peptides to T cells. The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5. [provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.177 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HLA-DRA | NM_019111.5 | c.*175G>A | 3_prime_UTR_variant | Exon 5 of 5 | ENST00000395388.7 | NP_061984.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HLA-DRA | ENST00000395388.7 | c.*175G>A | 3_prime_UTR_variant | Exon 5 of 5 | 6 | NM_019111.5 | ENSP00000378786.2 | |||
HLA-DRA | ENST00000374982.5 | c.*175G>A | 3_prime_UTR_variant | Exon 5 of 5 | 6 | ENSP00000364121.5 | ||||
ENSG00000299747 | ENST00000766007.1 | n.163-6555C>T | intron_variant | Intron 1 of 2 |
Frequencies
GnomAD3 genomes AF: 0.152 AC: 23107AN: 151966Hom.: 1897 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
23107
AN:
151966
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0831 AC: 130AN: 1564Hom.: 5 Cov.: 0 AF XY: 0.0876 AC XY: 69AN XY: 788 show subpopulations
GnomAD4 exome
AF:
AC:
130
AN:
1564
Hom.:
Cov.:
0
AF XY:
AC XY:
69
AN XY:
788
show subpopulations
African (AFR)
AF:
AC:
6
AN:
56
American (AMR)
AF:
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
AC:
2
AN:
70
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AF:
AC:
116
AN:
1266
European-Non Finnish (NFE)
AF:
AC:
0
AN:
48
Other (OTH)
AF:
AC:
6
AN:
120
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.152 AC: 23113AN: 152084Hom.: 1894 Cov.: 31 AF XY: 0.150 AC XY: 11120AN XY: 74350 show subpopulations
GnomAD4 genome
AF:
AC:
23113
AN:
152084
Hom.:
Cov.:
31
AF XY:
AC XY:
11120
AN XY:
74350
show subpopulations
African (AFR)
AF:
AC:
5056
AN:
41466
American (AMR)
AF:
AC:
1911
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
361
AN:
3472
East Asian (EAS)
AF:
AC:
652
AN:
5182
South Asian (SAS)
AF:
AC:
332
AN:
4816
European-Finnish (FIN)
AF:
AC:
2179
AN:
10564
Middle Eastern (MID)
AF:
AC:
19
AN:
292
European-Non Finnish (NFE)
AF:
AC:
12186
AN:
67982
Other (OTH)
AF:
AC:
313
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1007
2015
3022
4030
5037
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
313
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.